Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis

Shuyan Zhu,Huimin Shan,Jianqiao Li,Lijie Pan,Shudan Wang,Jing Zhu,Hui Guo,Fenghua Mi,Xinyi Wu,Jia Yin,Kunpeng Pang

DOI: https://doi.org/10.3389/fphar.2023.1161682

IF: 5.6

2023-02-21

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.996635.].

pharmacology & pharmacy

What problem does this paper attempt to address?

Corrigendum: Editorial: Recent innovations to inhibit scar formation for better skin regeneration.

Xiao-Ying Lin,Tao Zan,Xiao-Li Wu,Guang-Shuai Li,Wei-Qiang Tan

DOI: https://doi.org/10.3389/fsurg.2024.1351577

IF: 1.8

2024-01-01

Frontiers in Surgery

Abstract:[This corrects the article DOI: 10.3389/fsurg.2023.1325832.].
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

Zhou Guo,Jiamin Lin,Kai Sun,Jiayou Guo,Xudong Yao,Genchun Wang,Liangcai Hou,Jingting Xu,Jiachao Guo,Fengjing Guo

DOI: https://doi.org/10.3389/fphar.2023.1199951

IF: 5.6

2023-05-12

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.791376.].

pharmacology & pharmacy
Corrigendum to “neuroprotective Effect of Nicorandil Through Inhibition of Apoptosis by the PI3K/Akt1 Pathway in a Mouse Model of Deep Hypothermic Low Flow” [journal of the Neurological Sciences Volume 357, Issues 1–2, 15 October 2015, Pages 119–125]

Di Yu,Changfeng Fan,Weiyan Zhang,Zhongyuan Wen,Liang Hu,Lei Yang,Yu Feng,Xuming Mo

DOI: https://doi.org/10.1016/j.jns.2019.05.007

IF: 4.4

2019-01-01

Journal of the Neurological Sciences

Abstract:The authors regret Dr. Kejie Yin is not an author of this publication. The authors would like to apologise for any inconvenience caused. Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K/Akt1 pathway in a mouse model of deep hypothermic low flowJournal of the Neurological SciencesVol. 357Issues 1-2PreviewNicorandil exerts a protective effect on ischemia–reperfusion (I/R) injury in the brain and kidney through anti-apoptotic mechanisms. However, the mechanism by which nicorandil protects against I/R injury induced by deep hypothermic low flow (DHLF) remains unclear. Full-Text PDF
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Yusi Chen,Jun Luo,Jingyuan Chen,Eugene Kotlyar,Zilu Li,Wenjie Chen,Jiang Li

DOI: https://doi.org/10.3389/fphar.2022.891907

IF: 5.6

2022-04-11

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.811700.].

pharmacology & pharmacy
Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Jiajia Li,Yupeng Jiang,Qin Dai,Yue Yu,Xin Lv,Yan Zhang,Xiaohua Liao,Liyun Ao,Gaoyun Hu,Jie Meng,Zhangzhe Peng,Lijian Tao,Yanyun Xie

DOI: https://doi.org/10.3389/fphar.2023.1188615

IF: 5.6

2023-04-06

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1043945.].

pharmacology & pharmacy
Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Xue-Fei Wu,Chun Li,Guang Yang,Ying-Zi Wang,Yan Peng,Dan-Dan Zhu,Ao-Ran Sui,Qiong Wu,Qi-Fa Li,Bin Wang,Na Li,Yue Zhang,Bi-Ying Ge,Jie Zhao,Shao Li

DOI: https://doi.org/10.3389/fphar.2021.791953

IF: 5.6

2021-11-26

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.704715.].

pharmacology & pharmacy
Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

Mingming Fan,Huijuan Xiao,Dingyun Song,Lili Zhu,Jie Zhang,Xinran Zhang,Jing Wang,Huaping Dai,Chen Wang

DOI: https://doi.org/10.3389/fphar.2022.1109002

IF: 5.6

2023-01-18

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.848435.].

pharmacology & pharmacy
Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Hong-guang Wang,Hua Yan,Chen Wang,Mi-mi Li,Xin-ze Lv,Hai-dong Wu,Zhan-hai Fang,Dong-li Mo,Zhi-yuan Zhang,Bin Liang,Ke-guan Lai,Jing-yu Bao,Xue-jia Yang,Hong-juan Zhao,Shuang Chen,Yi-mu Fan,Xiao-guang Tong

DOI: https://doi.org/10.3389/fphys.2022.881750

IF: 4

2022-07-22

Frontiers in Physiology

Abstract:[This corrects the article DOI: 10.3389/fphys.2020.00899.].

physiology
Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Huan Shi,Xin-Yu LI,Yao Chen,Xing Zhang,Yong Wu,Zi-Xuan Wang,Pan-Hong Chen,Hui-Qi Dai,Ji Feng,Sayantan Chatterjee,Zhong-Jie Li,Xiao-Wei Huang,Hong-Qiao Wei,Jigang Wang,Guo-Dong Lu,Jing Zhou

DOI: https://doi.org/10.3389/fphar.2020.640750

IF: 5.6

2021-02-08

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.534171.].

pharmacology & pharmacy
Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Song Miao,Jie Lü,Weiqi Dai,Wei Fan,Ling Xu,Kan Chen,Lei He,Ping Cheng,Yan Zhang,Chengfen Wang,Dong Wu,Jing Yang,Rong Zhu,Huawei Zhang,Yingqun Zhou,Chuanyong Guo

DOI: https://doi.org/10.1155/2016/5434275

2016-01-01

Mediators of Inflammation

Abstract:[This corrects the article DOI: 10.1155/2013/461536.].
Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Qiang Wang,Yuemei Xi,Binyang Chen,Hairong Zhao,Wei Yu,De Xie,Weidong Liu,Furong He,Chenxi Xu,Jidong Cheng

DOI: https://doi.org/10.3389/fphar.2022.1022539

IF: 5.6

2022-11-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.907133.].

pharmacology & pharmacy
Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis

Jiaxuan Wu,Wenfeng Cai,Ruiming Du,Haiyang Li,Bin Wang,Yanqiong Zhou,Daifei Shen,Huimin Shen,Yang Lan,Lesi Chen,Xiaoxia Zheng,Danmei Huang,Ganggang Shi

DOI: https://doi.org/10.3389/fmolb.2022.901322

IF: 6.113

2022-04-13

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.768594.].

biochemistry & molecular biology
Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Hongjun Kuang,Xinzhou Zhu,Huan Chen,Han Tang,Hong Zhao

DOI: https://doi.org/10.3389/fimmu.2024.1468179

2024-08-16

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1319863.].
Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Yajing Chen,Tingting Wu,Heng Li,Xuan Li,Qing Li,Xiaoying Zhu,Mei Yu,Sheng-Han Kuo,Fang Huang,Yun-Cheng Wu

DOI: https://doi.org/10.3389/fnagi.2021.620015

IF: 4.8

2021-07-06

Frontiers in Aging Neuroscience

Abstract:[This corrects the article DOI: 10.3389/fnagi.2019.00044.].

neurosciences,geriatrics & gerontology,gerontology
Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis

Jinming Zhang,Wenshan Zhong,Yuanyuan Liu,Weimou Chen,Ye Lu,Zhaojin Zeng,Yujie Qiao,Haohua Huang,Xuan Wan,Wei Li,Xiaojing Meng,Fei Zou,Shaoxi Cai,Hangming Dong

DOI: https://doi.org/10.3389/fphar.2024.1296214

2024-08-12

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.708462.].
Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

Jianyu Liu,Minghai Tang,Tao Li,Zhengying Su,Zejiang Zhu,Caixia Dou,Yan Liu,Heying Pei,Jianhong Yang,Haoyu Ye,Lijuan Chen

DOI: https://doi.org/10.3389/fphar.2022.1000887

IF: 5.6

2022-09-27

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.811682.].

pharmacology & pharmacy
Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Jing Zhu,Xian-he Lin

DOI: https://doi.org/10.1016/j.heliyon.2023.e17578

IF: 3.776

2023-06-01

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2023.e15311.].

Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis

Corrigendum: Editorial: Recent innovations to inhibit scar formation for better skin regeneration.

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

Corrigendum to “neuroprotective Effect of Nicorandil Through Inhibition of Apoptosis by the PI3K/Akt1 Pathway in a Mouse Model of Deep Hypothermic Low Flow” [journal of the Neurological Sciences Volume 357, Issues 1–2, 15 October 2015, Pages 119–125]

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study

Corrigendum: Protective effects of Mefunidone on ischemia-reperfusion injury/folic acid-induced acute kidney injury

Corrigendum: Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Corrigendum: Quercetin Induces Apoptosis Via Downregulation of VEGF/Akt Signaling Pathway in Acute Myeloid Leukemia Cells

Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis

Corrigendum: The immunomodulatory mechanism of acupuncture treatment for ischemic stroke: research progress, prospects, and future direction

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis

Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

Corrigendum to “Safety and efficacy of ablation index-guided high-power ablation for the treatment of atrial fibrillation” [Heliyon 9 (4), (April 2023) Article e15311]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]